Di Pede Di Pede

Mrs. Di Pede Di Pede


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
GFGiovina Di Felice
Giovina Di Felice
MVMatteo Vidali
Matteo Vidali
GPGelsomina Parisi
Gelsomina Parisi
SPSimona Pezzi
Simona Pezzi
DPDi Pede Di Pede
Di Pede Di Pede
OPOttavia Porzio
Ottavia Porzio
Background: The objective of this study was to establish the age and sex-dependent reference intervals for coagulation assays evaluated in healthy children, ranging from 0 days to 16 years old. Methods: PT, aPTT, Fibrinogen (functional), Antithrombin activity, Protein C anticoagulant activity, Protein S free antigen, Thrombin time, D-Dimer, Von Willebrand Factor antigen, Lupus anticoagulant (screening), extrinsic and intrinsic pathway factors, and activated Protein C resistance were evaluated using STA-R Max2. Results: A total of 1280 subjects (671 males and 609 females) were divided into five groups, according to their age: 0–15 days (n = 280, 174 M and 106 F), 15–30 days (n = 208, 101 M and 107 F), 1–6 months (n = 369, 178 M and 191 F), 6–12 months (n = 214, 110 M and 104 F), and 1–16 years (n = 209, 108 M and 101 F). The 95% reference intervals and the 90% CI were established using the Harrell–Davis bootstrap method and the bootstrap percentile method, respectively. Conclusions: The present study supports the concept that adult and pediatric subjects should be evaluated using different reference intervals, at least for some coagulation tests, to avoid misdiagnosis, which can potentially lead to serious consequences for patients and their families, and ultimately the healthcare system.

10 December 2010 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
DMDiego Martinelli
Diego Martinelli
ADAndrea Dotta
Andrea Dotta
LMLaura Massella
Laura Massella
SPStefano Picca
Stefano Picca
DPDi Pede Di Pede
Di Pede Di Pede
CDCarlo Dionisi-Vici
Carlo Dionisi-Vici

26 July 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
DRDomenico Umberto De Rose
Domenico Umberto De Rose
VCVenere Cortazzo
Venere Cortazzo
MAMarilena Agosta
Marilena Agosta
PBPaola Bernaschi
Paola Bernaschi
MRMaria Paola Ronchetti
Maria Paola Ronchetti
ADAndrea Dotta
Andrea Dotta
(1) Background: The literature reports a low risk of serious bacterial infections (SBIs) in febrile infants presenting with bronchiolitis or respiratory syncytial virus infection, but current microbiological techniques have a higher accuracy. (2) Methods: We assessed the risk of SBIs in neonates and infants with bronchiolitis from 2021 to 2023. We also evaluated C-reactive protein, procalcitonin, and leukocyte values. (3) Results: We included 242 infants. Blood cultures (BCs) were performed in 66/242 patients, with a positivity rate of 9.1% (including one BC with Staphylococcus hominis, considered as a contaminant). The cerebrospinal fluid culture was performed in 6/242 patients, and the results were all negative. Infection markers did not discriminate infants with positive BCs from those with negative ones. (4) Conclusions: Blood cultures should be performed in neonates and young infants with bronchiolitis fever, as the sepsis risk is not negligible. Conversely, our proposed algorithm is to wait for the respiratory panel results before decision-making for a lumbar puncture. Further studies are needed to understand lumbar puncture requirements.

10 September 2025 in Genes
Verified
Journal Article
Open access
PDF file
DPDi Pede Di Pede
Di Pede Di Pede
MMMonia Magliozzi
Monia Magliozzi
LVLaura Valfré
Laura Valfré
MDMaria Lisa Dentici
Maria Lisa Dentici
FPFlaminia Pugnaloni
Flaminia Pugnaloni
MDMaria Cristina Digilio
Maria Cristina Digilio
Background/Objectives: The etiology of congenital diaphragmatic hernia (CDH) remains unknown in over 50% of cases, although multiple heterogeneous causative defects have been identified. Emerging evidence suggests that specific genes and molecular pathways involved in connective tissue biology may contribute to CDH development. Associations between CDH and connective tissue disorders have been reported, including cases in Marfan syndrome and a prevalence of CDH in 34% of patients with arterial tortuosity syndrome. Noticing joint laxity in several CDH patients, we aimed to investigate the presence of genetic variants linked to connective tissue disorders in this subgroup, focusing on patients enrolled in the follow-up program at Bambino Gesù Children’s Hospital. Methods: We selected patients diagnosed with CDH who also exhibited joint laxity based on a positive Beighton scale. These individuals underwent molecular analysis targeting genes known to be associated with heritable connective tissue disorders. Results: Genetic testing revealed variants in several genes across our patient series. These included mutations in FBN1, FBN2, ZNF469, VEGFA, NOTCH1, ELN, MCTP2, and SMAD6. In some cases, the variants were inherited paternally, while others appeared de novo. Most of these variants were classified as of unknown significance according to ACMG guidelines. Conclusions: (1) Several “variants of unknown significance” in different genes causative for connective tissue disorders have been detected in half of the present series of patients with CDH and joint laxity; (2) although the majority of the variants are classified accordingly to the ACMG as “variants of unknown significance”, a role of predisposition or susceptibility to CDH cannot be excluded; (3) a precise clinical evaluation for features of connective disorders should be recommended in the diagnostic workflow of patients with CDH.